Carlyle makes new appointments as it completes OCD buy
This article was originally published in Clinica
Executive Summary
Ortho-Clinical Diagnostics (OCD) officially transferred from Johnson & Johnson ownership to The Carlyle Group on 30 June, and Carlyle did not waste time appointing new personnel. New CEO Martin Madaus announced several executive suite changes; he himself was named OCD’s new leader in February. Mr Madaus was formerly executive chairman of Quanterix, and has 25 years’ experience in the diagnostics and life science industries.